Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects

Delamanid is a medicinal product approved for treatment of multidrug-resistant tuberculosis. Three studies were conducted to evaluate the potential drug-drug interactions between delamanid and antiretroviral drugs, including ritonavir, a strong inhibitor of CYP3A4, and selected anti-TB drugs, includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallikaarjun, Suresh, Wells, Charles, Petersen, Carolyn, Paccaly, Anne, Shoaf, Susan E., Patil, Shiva, Geiter, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038266/
https://www.ncbi.nlm.nih.gov/pubmed/27458223
http://dx.doi.org/10.1128/AAC.00509-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038266/
https://www.ncbi.nlm.nih.gov/pubmed/27458223
http://dx.doi.org/10.1128/AAC.00509-16

Ejemplares similares